Cargando…
Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling
The endocannabinoid 2-arachidonoylglycerol (2-AG) is predominantly metabolized by monoacylglycerol lipase (MAGL) in the brain. Selective inhibitors of MAGL provide valuable insights into the role of 2-AG in a variety of (patho)physiological processes and are potential therapeutics for the treatment...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465256/ https://www.ncbi.nlm.nih.gov/pubmed/36105202 http://dx.doi.org/10.3389/fphar.2022.941522 |
_version_ | 1784787756265766912 |
---|---|
author | Deng, Hui Zhang, Qianwen Lei, Qian Yang, Na Yang, Kai Jiang, Jianbing Yu, Zhiyi |
author_facet | Deng, Hui Zhang, Qianwen Lei, Qian Yang, Na Yang, Kai Jiang, Jianbing Yu, Zhiyi |
author_sort | Deng, Hui |
collection | PubMed |
description | The endocannabinoid 2-arachidonoylglycerol (2-AG) is predominantly metabolized by monoacylglycerol lipase (MAGL) in the brain. Selective inhibitors of MAGL provide valuable insights into the role of 2-AG in a variety of (patho)physiological processes and are potential therapeutics for the treatment of diseases such as neurodegenerative disease and inflammation, pain, as well as cancer. Despite a number of MAGL inhibitors been reported, inhibitors with new chemotypes are still required. Here, we developed a substrate-based fluorescence assay by using a new fluorogenic probe AA-HNA and successfully screened a focused library containing 320 natural organic compounds. Furthermore, we applied activity-based protein profiling (ABPP) as an orthogonal method to confirm the inhibitory activity against MAGL in the primary substrate-based screening. Our investigations culminated in the identification of two major compound classes, including quinoid diterpene (23, cryptotanshinone) and β-carbolines (82 and 93, cis- and trans-isomers), with significant potency towards MAGL and good selectivity over other 2-AG hydrolases (ABHD6 and ABHD12). Moreover, these compounds also showed antiproliferative activities against multiple cancer cells, including A431, H1975, B16-F10, OVCAR-3, and A549. Remarkably, 23 achieved complete inhibition towards endogenous MAGL in most cancer cells determined by ABPP. Our results demonstrate the potential utility of the substrate-based fluorescence assay in combination with ABPP for rapidly discovering MAGL inhibitors, as well as providing an effective approach to identify potential targets for compounds with significant biological activities. |
format | Online Article Text |
id | pubmed-9465256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94652562022-09-13 Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling Deng, Hui Zhang, Qianwen Lei, Qian Yang, Na Yang, Kai Jiang, Jianbing Yu, Zhiyi Front Pharmacol Pharmacology The endocannabinoid 2-arachidonoylglycerol (2-AG) is predominantly metabolized by monoacylglycerol lipase (MAGL) in the brain. Selective inhibitors of MAGL provide valuable insights into the role of 2-AG in a variety of (patho)physiological processes and are potential therapeutics for the treatment of diseases such as neurodegenerative disease and inflammation, pain, as well as cancer. Despite a number of MAGL inhibitors been reported, inhibitors with new chemotypes are still required. Here, we developed a substrate-based fluorescence assay by using a new fluorogenic probe AA-HNA and successfully screened a focused library containing 320 natural organic compounds. Furthermore, we applied activity-based protein profiling (ABPP) as an orthogonal method to confirm the inhibitory activity against MAGL in the primary substrate-based screening. Our investigations culminated in the identification of two major compound classes, including quinoid diterpene (23, cryptotanshinone) and β-carbolines (82 and 93, cis- and trans-isomers), with significant potency towards MAGL and good selectivity over other 2-AG hydrolases (ABHD6 and ABHD12). Moreover, these compounds also showed antiproliferative activities against multiple cancer cells, including A431, H1975, B16-F10, OVCAR-3, and A549. Remarkably, 23 achieved complete inhibition towards endogenous MAGL in most cancer cells determined by ABPP. Our results demonstrate the potential utility of the substrate-based fluorescence assay in combination with ABPP for rapidly discovering MAGL inhibitors, as well as providing an effective approach to identify potential targets for compounds with significant biological activities. Frontiers Media S.A. 2022-08-29 /pmc/articles/PMC9465256/ /pubmed/36105202 http://dx.doi.org/10.3389/fphar.2022.941522 Text en Copyright © 2022 Deng, Zhang, Lei, Yang, Yang, Jiang and Yu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Deng, Hui Zhang, Qianwen Lei, Qian Yang, Na Yang, Kai Jiang, Jianbing Yu, Zhiyi Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling |
title | Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling |
title_full | Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling |
title_fullStr | Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling |
title_full_unstemmed | Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling |
title_short | Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling |
title_sort | discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465256/ https://www.ncbi.nlm.nih.gov/pubmed/36105202 http://dx.doi.org/10.3389/fphar.2022.941522 |
work_keys_str_mv | AT denghui discoveringmonoacylglycerollipaseinhibitorsbyacombinationoffluorogenicsubstrateassayandactivitybasedproteinprofiling AT zhangqianwen discoveringmonoacylglycerollipaseinhibitorsbyacombinationoffluorogenicsubstrateassayandactivitybasedproteinprofiling AT leiqian discoveringmonoacylglycerollipaseinhibitorsbyacombinationoffluorogenicsubstrateassayandactivitybasedproteinprofiling AT yangna discoveringmonoacylglycerollipaseinhibitorsbyacombinationoffluorogenicsubstrateassayandactivitybasedproteinprofiling AT yangkai discoveringmonoacylglycerollipaseinhibitorsbyacombinationoffluorogenicsubstrateassayandactivitybasedproteinprofiling AT jiangjianbing discoveringmonoacylglycerollipaseinhibitorsbyacombinationoffluorogenicsubstrateassayandactivitybasedproteinprofiling AT yuzhiyi discoveringmonoacylglycerollipaseinhibitorsbyacombinationoffluorogenicsubstrateassayandactivitybasedproteinprofiling |